S'abonner

Smoking habits in the Middle East and North Africa: Results of the BREATHE study - 04/01/13

Doi : 10.1016/S0954-6111(12)70011-2 
Adel Khattab a, Arshad Javaid b, Ghali Iraqi c, Ashraf Alzaabi d, Ali Ben Kheder e, Marie-Louise Koniski f, Naem Shahrour g, Samya Taright h, Magdy Idrees i, Mehmet Polatli j, Nauman Rashid k, Abdelkader El Hasnaoui k, A,

on behalf of the BREATHE Study GroupB

  BREATHE Steering Committee members (in alphabetical order of names): Ashraf Alzaabi, Zayed Military Hospital, Abu Dhabi, UAE; Majed Beji, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Hospital, Tunis, Tunisia; Ali Ben Kheder, Abderrahmane Mami Hospital, Tunis, Tunisia; Majdy Idrees, Riyadh Military Hospital, Riyadh, Saudi Arabia; Ghali Iraqi, Moulay Youssef Hospital, Rabat, Morocco; Arshad Javed, Lady Reading Hospital, Peshawar, Pakistan; Javaid Ahmed Khan, Aga Khan University Hospital, Karachi, Pakistan; Adel Khattab, Ain Shams University, Cairo, Egypt; Marie Louise Koniski, Lebanese American University, Beirut, Lebanon; Bassam Mahboub, University of Sharjah, Sharjah, UAE; Salim Nafti, Mustapha Bacha Hospital, Algiers, Algeria; Nathir M. Obeidat, University of Jordan, Amman, Jordan; Mehmet Polatli, Adnan Menderes University, Aydin, Turkey; Abdullah Sayiner, Ege University, Izmir, Turkey; Naem Shahrour, Alasaad University Hospital, Damascus, Syria; Mohamed Awad Tageldin, Ain Shams University, Cairo, Egypt; Samya Taright, Bab-El-Oued Hospital, Algiers, Algeria; Esra Uzaslan, Uludag University Medical Faculty, Bursa, Turkey; Siraj Wali, King Abdulaziz University, Jeddah, Saudi Arabia.

a Ain Shams University, Cairo, Egypt 
b Lady Reading Hospital, Peshawar, Pakistan 
c Moulay Youssef Hospital, Rabat, Morocco 
d Zayed Military Hospital, Abu Dhabi, UAE 
e Abderrahmane Mami Hospital, Tunis, Tunisia 
f Lebanese American University, Beirut, Lebanon 
g Alasaad University Hospital, Damascus, Syria 
h Bab-El-Oued Hospital, Algiers, Algeria 
i Riyadh Military Hospital, Riyadh, Saudi Arabia 
j Adnan Menderes University, Aydin, Turkey 
k GlaxoSmithKline, Dubai, UAE 

* Corresponding author. Dr Abdelkader El Hasnaoui, GlaxoSmithKline, PO Box 50199, Dubai, United Arab Emirates. Tel.: +971 4 409 6305; fax: +971 4 332 3071

Summary

Few recent comparative data exist on smoking habits in the Middle East and North Africa (MENA) region. The objective of this analysis was to evaluate smoking patterns in a large general population sample of individuals aged ≥40 years in ten countries in the region (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey and United Arab Emirates), together with Pakistan, using a standardised methodology. A random sample of 457,258 telephone numbers was generated and called. This identified 65,154 eligible subjects, of whom 62,086 agreed to participate. A screening questionnaire was administered to each participant, which included six questions relating to cigarette consumption and waterpipe use. The age- and gender-adjusted proportion of respondents reporting current or past smoking of cigarettes or waterpipes was 31.2% [95% CI: 30.9–31.6%]. This proportion was significantly higher (p < 0.001) in men (48.0%) than in women (13.8%), but no relevant differences were observed between age groups. Smoking rates were in general lowest in the Maghreb countries and Pakistan and highest in the Eastern Mediterranean countries, ranging from 15.3% in Morocco to 53.9% in Lebanon. Consumption rates were 28.8% [28.4–29.2%] for cigarette smoking and 3.5% [3.4–3.6%] for waterpipe use. Use of waterpipes was most frequent in Saudi Arabia (8.5% of respondents) but remained low in the Maghreb countries (< 1.5%). Cumulative cigarette exposure was high, with a mean number of pack·years smoked of 18.5±20.5 for women and 29.1±26.2 for men. In conclusion, smoking is a major health issue in the MENA region.

Le texte complet de cet article est disponible en PDF.

Keywords : Smoking rates, Smoking habits, Middle East, North Africa, Waterpipes, Cigarettes


Plan


 BREATHE core team members: Abdelkader El Hasnaoui, GlaxoSmithKline, Dubai, UAE; Nauman Rashid, GlaxoSmithKline, Dubai, UAE; Aïcha Lahlou, MS Health, Rabat, Morocco; Adam Doble, Foxymed, Paris, France, Hocine Salhi, Foxymed, Paris, France and Chakib Nejjari Faculty of Medicine of Fez, Fez, Morocco.
Conflict of interest statement
AK, AJ, GI, AA, ABK, M-LK, NS, ST and MP have received honoraria from GlaxoSmithKline Laboratories for their contribution to the BREATHE study. MI has received honoraria from GlaxoSmithKline Laboratories for his contribution to the BREATHE study and has received speaking honoraria from AstraZeneca, Novartis, Sanofi, MSD, Pfizer, Actelion and Bayer. NR and AEH are employees of GlaxoSmithKline Laboratories, which funded the BREATHE study and market a number of treatments for COPD.


© 2012  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 106 - N° S2

P. S16-S24 - décembre 2012 Retour au numéro
Article précédent Article précédent
  • Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study
  • Abdelkader El Hasnaoui, Nauman Rashid, Aicha Lahlou, Hocine Salhi, Adam Doble, Chakib Nejjari, on behalf of the BREATHE Study Group A
| Article suivant Article suivant
  • Distribution of COPD-related symptoms in the Middle East and North Africa: Results of the BREATHE study
  • Mohamed Awad Tageldin, Salim Nafti, Javaid Ahmed Khan, Chakib Nejjari, Majed Beji, Bassam Mahboub, Nathir M. Obeidat, Esra Uzaslan, Abdullah Sayiner, Siraj Wali, Nauman Rashid, Abdelkader El Hasnaoui, on behalf of the BREATHE Study Group B

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.